However,instead of attacking cancer cells, they are typically co-opted to support tumor growth, metastasis, and therapeutic ...

Round led by Lumira Ventures and Roche Venture Fund with new investment from SanofiCHICAGO, June 18, 2026 (GLOBE NEWSWIRE) -- COUR Pharma, a clinical-stage biotechnology company developing ...

Good morning, and welcome to the Passage Bio-Remix Therapeutics Merger Agreement Announcement Conference Call. I would like to remind you that this call is being recorded for replay. I will now turn ...

The gut microbiome is not a mere spectator but an active player in colorectal cancer (CRC), driving tumor initiation and ...

Natera, Inc. , a global leader in cell-free DNA and precision medicine, and Aveta Biomics, Inc., a clinical-stage immuno-oncology company advancing first-in-class oral immunotherapies for solid tumors ...

Two Danville families are betting big on ostriches as a safe alternative for Alpha-Gal Syndrome sufferers as the tick-borne illness spreads.

A study may help explain why previous attempts to develop a staph vaccine have failed, while also suggesting a new approach to vaccine design that focuses on activating an untapped set of immune cells ...

Targeting PTMs in cancer. Schematic overview of major PTMs in tumor-targeted therapy, highlighting the principal modification classes and their associated targeting strategies. P, phosphorylation; Ac, ...

Cancer has often been explained through mutations in deoxyribonucleic acid (DNA) or changes in ribonucleic acid (RNA), but these layers do not fully explain why tumors with similar genetic profiles ...

Explore why SpaceX is a Strong Buy and Tesla, Inc. a Buy, why a merger could destroy value, and how to allocate 1–5% in your ...